JUL 31, 2026 · PHASE 1 TRIAL
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
ClinicalTrials.gov
This is a Phase 1 registry record for a planned interventional study with no results posted; it describes study design and enrollment targets only.
Reported
Planned enrollment90 participants (estimated)
Primary outcome measurePDE4B radioligand binding increased in medi…
Study duration48 months